Home / Expertise / Intellectual Property

Intellectual Property

Spain

In the current economic climate, intangible assets are of significant value to companies. Said assets, essential for generating competitive advantage and avoiding the loss of opportunity, are becoming increasingly threatened by risks. Receiving sound advice on industrial and intellectual property matters provides the key to effectively protecting brands, patents, designs, copyrights and know-how.

The CMS team comprises more than 400 specialist lawyers located in 43 countries. Thanks to our vast experience advising on intellectual and industrial property matters, we are able to understand business needs and provide a strategy aligned to each client’s sector, helping them to achieve their creative and commercial goals.

We advise companies throughout the digital economy value chain, from content firms to those which offer or require connectivity and technology services, as well as publishers and audiovisual and visual arts companies. We also benefit from vast experience in related areas such as advertising, unfair competition and the protection of honour, privacy and personal image.

Read more Read less

Feed

Show only
21 April 2021
Lego A/S v EUIPO: Lego re­tains design re­gis­tra­tion for its icon­ic Lego...
The Second Cham­ber of the Gen­er­al Court in Lego A/S v EUIPO (Case T-515/19) has an­nulled a de­cision of the EU In­tel­lec­tu­al Prop­erty Of­fice (“EUIPO”) to de­clare in­val­id the design of a Lego brick...
23 March 2021
The En­larged Board of the European Pat­ent Of­fice has giv­en a mo­ment­ous...
The En­larged Board of the European Pat­ent Of­fice heard or­al ar­gu­ments in Ju­ly 2020 con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion.  This rare event was video streamed to over 1600 pat­ent stake­hold­ers...
05 March 2021
New EPO Guidelines on an­ti­body claims provide fur­ther clar­ity for ap­plic­ants
In­tro­duc­tion The EPO has now pub­lished their re­vised Guidelines for Ex­am­in­a­tion 2021[1] which con­tain new sec­tions de­tail­ing EPO prac­tice in re­la­tion to an­ti­bod­ies for the first time, en­ter­ing in­to force...
24 February 2021
COV­ID and ViCo: EPO re­fer­ral to the En­larged Board of Ap­peal
In the last year, the COV­ID-19 pan­dem­ic has res­ul­ted in a large pro­por­tion of the leg­al sec­tor trans­ition­ing to a ‘work from home’ ar­range­ment, with meet­ings tak­ing place re­motely. Non-es­sen­tial travel...
17 February 2021
Com­puls­ory li­cens­ing in Spain
1. What is the defin­i­tion of com­puls­ory li­cens­ing? Span­ish reg­u­la­tion does not provide a spe­cif­ic defin­i­tion of com­puls­ory li­cens­ing.In gen­er­al terms, com­puls­ory li­cens­ing refers to a spe­cial re­gime...
Comparable
16 February 2021
Fight­ing poor med­ic­a­tion ad­her­ence in the European Uni­on: The Grav­it­ate-Health...
Nowadays, European cit­izens can ob­tain a great amount of in­form­a­tion (on­line and off­line) about any medi­cine. However, this in­form­a­tion is in many cases un­re­li­able and dif­fi­cult to un­der­stand, en­cour­aging...
12 February 2021
‘It’s like milk but made for hu­mans’: Gen­er­al Court over­turns EUIPO’s re­fus­al...
On 20 Janu­ary 2021, the Gen­er­al Court (“GC”) handed down its judg­ment in the ap­peal brought by Oatly AB (“Oatly”) against the de­cision of the EU In­tel­lec­tu­al Prop­erty Of­fice (“EUIPO”) to re­fuse...
11 February 2021
New EPO Guidelines now pub­lished re­gard­ing amend­ing the de­scrip­tion: what’s...
In­tro­duc­tion In Oc­to­ber 2020, CMS pub­lished an art­icle ‘New EPO Guidelines ex­pec­ted re­gard­ing amend­ing a de­scrip­tion: what’s all the fuss about?’, which has been the cata­lyst for dis­cus­sion in the...
15 December 2020
Five years after Hua­wei ZTE FRAND li­cens­ing ob­lig­a­tions again be­fore the...
On 26 Novem­ber 2020, the Düs­sel­dorf Re­gion­al Court an­nounced that it would sus­pend a pat­ent in­fringe­ment pro­ceed­ing and refer key ques­tions on com­puls­ory li­cens­ing of stand­ard es­sen­tial pat­ents (SEP)...
01 December 2020
EPO pri­or­ity claim en­ti­tle­ment – the “same ap­plic­ants” ap­proach up­held
In a Press Com­mu­niqué dated 6 Novem­ber 2020, the EPO sum­mar­ises the Tech­nic­al Board of Ap­peal 3.3.08 writ­ten de­cision re­cently is­sued in case T 844/18 con­firm­ing the re­voc­a­tion of a pat­ent re­lated to...
18 November 2020
CMS Spain se­cures a sig­ni­fic­ant win for At­res­me­dia in land­mark me­dia case
The ECJ ruled today in a land­mark case fol­low­ing a pre­lim­in­ary rul­ing case re­lat­ing to copy­right and col­lect­ive man­age­ment of copy­rights and neigh­bour­ing rights, de­clar­ing that users (broad­casters) do...
29 October 2020
EU Gen­er­al Court cla­ri­fies in­ter­pret­a­tion of “sat­is­fact­ory meth­od” in the...
In the re­cent case of Me­dac Gesell­schaft für klin­is­che Spezi­al­prä­par­ate mbH v European Com­mis­sion, the EU Gen­er­al Court has an­nulled a de­cision of the European Com­mis­sion in which it held that the ap­plic­ant’s...